A 2-phase study was conducted to evaluate the ability of the NEB-1 strain of porcine reproductive and respiratory syndrome virus (PRRSV) to potentiate common bacterial pathogens of swine. In phase I, 25 of 50 4-5-week-old specific-pathogen-free (SPF) pigs were exposed to NEB-1 PRRSV (day 0). Seven days after virus inoculation, 8 groups received 1 of 4 bacterial pathogens: Haemophihs parasuis, Streptococcus suis, Salmonella cholerasuis, and Pasteurella multocida. The ability of NEB-1 PRRSV to produce clinical disease, viremia, neutralizing antibody, gross and microscopic lesions and to potentiate bacterial pathogens was assessed. Response to NEB-1 PRRSV was similar among inoculated pigs; prolonged hyperthermia, lethargy, mild to moderate dyspnea, and cutaneous erythema were consistent clinical signs. No clinical differences were observed in groups after bacterial challenge. Virus was isolated from serum at weekly intervals through the end of the study, and all PRRSV-inoculated pigs had seroconverted by study termination. Two of 5 pigs died in non-PRRSV-inoculated groups challenged with H. parasuis and Streptococcus suis. Mortality in PRRSV-infected pigs was limited to 1 of 5 pigs from the Salmonella cholerasuis-challenged group. Gross lesions were seen in pigs dying after inoculation in H. parasuis-and Streptococcus suis-inoculated groups, in Salmonella cholerasuisand P. multocida-challenged pigs, and in 1 non-PRRSV-inoculated control pig. Microscopic lesions consisted of mild to moderate proliferative interstitial pneumonia, nonsuppurative myocarditis, lymphoid hyperplasia, and nonsuppurative encephalitis in PRRSV-inoculated pigs. Findings in phase I indicated that NEB-1 PRRSV does not potentiate bacterial disease while inducing consistent clinical signs, viremia, seroconversion, and microscopic lesions. Based upon initial findings in phase I, in phase II, 18 of 36 4-6-week-old SPF pigs were exposed to NEB-1 PRRSV (day 0). Two days after virus inoculation, 2 of 4 groups were exposed to either Streptococcus suis or P. multocida. Clinical findings were similar to those of phase I. One of 6 pigs died in each of the Streptococcus suis-challenged groups. Animals succumbed 3 and 5 days after bacterial challenge in the non-PRRSV-inoculated and PRRSV-inoculated groups, respectively. Mild gross and microscopic pulmonary lesions were observed. Phase II findings support the conclusions of phase I that NEB-1 PRRSV does not potentiate certain bacterial infections of swine.
. Bacterial inoculum levels and group assignments for pigs in phases I and II.
Materials and methods

Animals
Phase I. Fifty specific-pathogen-free (SPF) pigs, 4-5 weeks of age, were obtained from a commercial swine herd routinely monitored for evidence of atrophic rhinitis and mycoplasma pneumonia. Pigs were seronegative for PRRSV and pseudorabies virus. Pigs were ear-tagged, randomly assigned to groups of 5, and placed in 10 isolation rooms. Pigs were fed a nonmedicated commercial soybean-meal-based ration and had access to water ad libitum. Pigs were allowed to acclimate to their surroundings for 1 wk prior to study initiation.
Phase II. Thirty-six SPF pigs, 4-6 wk of age, were obtained from the same commercial herd utilized in phase I. Pigs were ear-tagged, randomly assigned to groups of 6, and placed in isolation rooms. Animal care procedures were the same as for phase I. Animals were allowed to acclimate to their surroundings for 5 days prior to study initiation.
Experimental design
Phase I. Pigs were divided into 5 principal and 5 control groups. On day 0 of the experiment, 25 pigs were intranasally challenged with NEB-1 PRRSV. On day 7, 5 non-PRRSVinfected and 5 PRRSV-infected pigs were inoculated with 1 of 4 bacterial agents ( Fig. 1) . Clinical signs were monitored daily from day -3 to day 27 of the study. Rectal temperatures, overall appearance (anorexia, lethargy, central nervous system signs, death), respiration (coughing, hyperpnea, shallow, labored) , feces (dry, loose, fluid), and ocular and nasal discharge were evaluated. Pigs were scored clinically on a scale of 0-3, with 0 = normal, 1 = sick, 2 = very sick, and 3 = dead. Pigs that did not die prior to termination of phase I were euthanized on day 27 or day 29.
Phase II. Pigs were divided into 3 principal and 3 control groups. On day 0, 18 pigs were intranasally challenged with NEB-1 PRRSV. On day 2 of the experiment, groups 1 and 2 and groups 3 and 4 were inoculated with P. multocida or Streptococcus suis, respectively, with the same inoculum as used in phase I. Evaluation of clinical parameters followed that of phase I. Pigs that did not die prior to termination of phase II were euthanized on day 9.
Experimental transmission of agents
Viral inoculum was prepared as previously described (Hesse RA, et al.: 1992, Abstr Conf Res Workers Anim Dis 42: 214, 215) . Inoculum contained 5.9 log 10 TCID 50 virus/ml and was inoculated intranasally at 2.5 ml/nare for each viruschallenged pig. Intranasal inoculations were made by injection via a 3-ml syringe equipped with a tip nebulizer. Bacterial pathogens were isolated by routine laboratory procedures. On day 7 (day 2 in phase II), groups were inoculated with their assigned bacterial pathogens via intranasal or intraperitoneal routes (Fig. 1) .
Haemophilus parasuis inoculum was prepared from stock culture. a Chocolate agar plates were inoculated with 0.15 ml and incubated at 37 C in a 5% CO 2 -enriched atmosphere. After 42 hr of incubation, plates were washed with 5 ml of Tris-buffered saline supplemented with NAD + and pooled. Percent turbidity of final culture preparation was 1.4% at 630 nm. Final inoculum level was 1.06 x 10 10 colony-forming units (CFU)/ml.
Streptococcus suis inoculum was prepared by inoculation of 2 ml of challenge stock a into 200 ml SYNTX supplemented with 5% horse serum. Cultures were incubated for 3 hr at 37 C with agitation. Challenge culture was dispensed to 3 50ml aliquots into 3 100-ml vials, labeled, and titrated for viability at T0' and T2 postharvest. The T2 sample was then stored on ice until inoculation. Turbidity of challenge inoculum was 13.4% at 630 nm, with final viability equal to 1.6 x 10 9 CFU/ml.
Salmonella cholerasuis inoculum was raised by inoculation of 2 ml of challenge stock a into 200 ml of trypticase soy broth (TSB). Culture was incubated for 3 hr at 37 C with agitation then diluted 1:35 (6 ml S. cholerasuis + 204 ml sterile saline). Challenge culture was treated as described above. Turbidity of undiluted stock was 35.2-37.2% at 630 nm. T2 levels after 1:35 dilution were equal to 2.01 x 10 7 CFU/ml for challenge.
Pasteurella multocida inoculum was prepared by inoculation of 1 ml of challenge stock a into 200 ml TSB. Culture was incubated for 18 hr at 37 C with agitation and then diluted 1:40 (5 ml P. multocida + 200 ml TSB). Challenge culture was dispensed as previously described. Turbidity of final challenge inoculum was 18% at 630 nm, with viability levels of 4.5 x 10 8 CFU/ml.
Serum samples
Blood samples were obtained from all pigs on days 0, 6, 13, and 20 (days 0, 3, 6, and 9 of phase II) and at necropsy. Samples were centrifuged and serum aliquoted for virus isolation and serum neutralization assay. Serum was inoculated at a 1:4 dilution with subsequent 10-fold dilutions onto monolayers of porcine alveolar macrophages (PAMs) in 96well, flat-bottom microtiter plates. Diluent medium consisted of Eagle's modified essential medium with HEPES (EMEM/ H) (30 ml of 1 M HEPES per liter of standard EMEM) and 7% fetal bovine serum, and 50 µg/ml of gentamicin was added. PRRSV Reference P-99 Undiluted Stock 23 a and samples to be titrated were serially diluted. Dilution tubes contained 1.8 ml of diluent, and transfer volumes of 0.2 ml were used to prepare the dilution series. Growth medium was removed from assay cells in 96-well plates by inversion of the plate and aseptically dumping into a suitable receptacle in a laminar flow hood. Viral dilutions were tested by adding 0.2 ml of each dilution to 6 wells of the empty 96-well plate containing assay cells. Dilutions were added from highest dilution of the sample to lowest. Plates were incubated at 37 C with a 5% CO 2 -enriched atmosphere for 4-5 days. Each well was observed for typical cytopathic effect (CPE) or lack of CPE; wells were scored positive or negative. Virus titers were calculated according to the number of positive and negative wells at the end-point dilutions. The method of Spearman and Karber in a customized computer program was used for the calculations, and virus titers were expressed as 1og 10 TC1D 50 /m1. For a titration to be valid, the titer of PRRSV reference stock had to fall within the previously determined range. If the value was not within the expected range, the assay was considered a "no test" and was repeated.
Serum neutralization (SN) assays were conducted as follows. Samples were diluted 2-fold in EMEM/H, and an equal volume (0.1 ml) of NEB-P9 virus with 100-300 TCID 50 was added to each well. The serum-virus mixture was incubated at 37 C for 1 hr. After incubation, 100 µl of serum-virus mixture was inoculated onto confluent monolayers of MA 104 cells grown in 96-well tissue culture plates. Inoculated assay plates were incubated for 5 days at 37 C in an incubator containing a humidified 5% CO 2 atmosphere. An input virus quanitation (back titration) plate was also included as part of the assay. Serial 10-fold dilutions of the SN challenge virus was added to a tissue culture plate containing 0.1 ml of the following dilutions of SN challenge virus: 10 0 , 10-1) 10-2 , 10 -3 , and 10 -4 . Actual TCID 50 of the SN challenge was calculated by the Spearman and Karber method. For the assay to be valid, the back titration average had to fall within 60-300 TCID 50 . A positive control antiserum was also included in the test system. Final readings by direct visual observation were conducted on day 5 postinoculation (PI). Final titers were determined from the highest serum dilution that was free of CPE. Calculations were based on the Spearman and Karber method. For the assay to be valid, the back titration and titer of the positive control antiserum had to fall within the previously determined range. If values did not fall in the expected range, the assay was considered a "no test" and was repeated.
Tissue virus isolation
In phase II, samples of thymus, bronchial lymph node, lung, heart, and spleen were collected at necropsy for virus isolation. Tissue weight was recorded. Five milliliters of EMEM/H was added to the tissues, and homogenization was performed with a stomacher tissue homogenizer. Tissue homogenates were centrifuged at 1,500 x g at 4 C for 10 min. Supematant was collected, inoculated onto PAMs, and treated as previously described for phase I.
Bacteriology
Samples were collected from pigs in each group for bacterial isolation: lung and pleural exudate (groups 1, 2); lung and tonsil (groups 3, 4); lung, tonsil, cecal lymph node, and cecum (groups 5, 6 and 9, 10); lung (groups 7, 8). Additional samples were collected for bacteriological evaluation based on gross necropsy observations. Tissues were collected similarly in phase II for respective groups in that study.
Tissues were plated on trypticase soy agar with 5% sheep blood (BA), Columbia CNA agar with 5% sheep blood (CNA), and MacConkey's agar (MAC). Plates were streaked for microbial isolation, and a feeder streak of Staphylococcus aureus was added for NAD+ supplementation. All plates were incubated for 18-24 hr at 37 C in a 5% CO 2 -enriched atmosphere. Bacterial isolates were selected for further biochemical screening based on colony morphology. Bacterial pathogens screened for included Streptococcus suis, P. multocida, A. pleuropneumoniae, H. parasuis, Bordetella bronchiseptica, and Salmonella spp.
To screen for Salmonella spp., portions of tissue specimens from each animal were minced and pooled into 60 ml of tetrathionate enrichment broth and incubated at 37 C for 18-24 hr. Each tetrathionate broth was subcultured onto brilliant green agar and MAC and then incubated at 37 C for an additional 18-24 hr. Non-lactose-fermenting colonies that morphologically resembled Salmonella spp. were screened as a percentage of total lung weight. Total lung weight was biochemically.
evaluated as a percentage of total body weight. 11 Positive identification of Streptococcus suis isolates was conducted as previously described. 8 Colonies of gram-positive cocci that exhibited alpha hemolysis on BA and CNA and were catalase negative were evaluated. Appropriate media were inoculated for Lancefield group D testing; growth in 6.5% NaCl broth; lactose, trehalose, sorbitol, salicin, and inulin fermentation; acetoin production (Voges-Proskauer [VP] test); and esculin hydrolysis. Isolates that were Group D, salt, and VP negative, that fermented lactose, trehalose, salicin, and inulin, and that were esculin positive were identified as S. suis.
Histopathology
Tissues collected for microscopic examination included lung, heart (including right and left ventricles and intraventricular septum), thymus, bronchial lymph node, brain, liver, kidney, spleen, urinary bladder, proximal small intestine, ileum, and colon. Formalin-fixed tissues were embedded in paraffin, sectioned at 5 µm, and stained with hematoxylin and eosin (HE).
Statistical analysis
Identification of Pasteurella multocida isolates was conducted as previously described. 1 Large gray colonies that grew on BA but not on MAC and had the characteristic musty odor of Pasteurella spp. were inoculated into triple sugar iron (TSI) agar and urea agar. Spot oxidase, spot indole, and catalase tests were also performed. Isolates that exhibited weak acid fermentation in the TSI agar and were urea negative and oxidase, indole, and catalase positive were identified as P. multocida.
Rectal temperatures, mortality rates, lung weights, and serological test results were evaluated using Student's t-test.
Results: phase I Clinical findings
Actinobacillus pleuropneumoniae identification was carried out as previously described. 1 Colonies around the Staphylococcus aureus feeder streak were subcultured onto a Haemophilus ID Quad Plate, containing X (hemin) and V (NAD) growth factors. Growth in the quadrant containing V factor only and growth and beta hemolysis in the quadrant containing X factor and V factor + 5% sheep blood was considered positive identification for A. pleuropneumoniae.
All PRRSV-inoculated pigs exhibited mild clinical signs, including variable degrees of dyspnea on days 2-5 PI. PRRSV-infected pigs were lethargic. Appetites and reaction to external stimuli were normal. Occasionally, cutaneous erythema was noted in individual pigs.
Haemophilus parasuis identification was also carried out as previously described. 2 Colonies around the Staphylococcus aureus feeder streak were subcultured onto Quad Plates. Growth in only the quadrant containing both X factor and V factor + 5% sheep blood was considered positive identification for H. parasuis. Positive identification of B. bronchiseptica isolates was performed in accordance with previously described procedures. 10 Small (approximately 1.0 mm) colonies that appeared after 24-48 hr and grew on both BA and MAC were inoculated into TSI, urea, and Simmon's citrate agar. Catalase and spot oxidase tests were also performed. Organisms that were catalase and oxidase positive, produced an alkaline-positive slant with no reaction in the butt of the TSI tube, split urea, and utilized citrate as the sole carbon source were identified as B. bronchiseptica.
Rectal temperatures in PRRSV-infected pigs rose significantly (P < 0.05) as early as 16 hours PI and were maintained to the time of bacterial inoculation on day 7 (Fig. 2) . Rectal temperatures of PRRSV-infected pigs remained significantly higher than those of uninoculated pigs for all groups except groups 9 and 10, where there was no statistically significant difference. Clinical signs after bacterial inoculation were similar for all groups. Mortality was noted in groups 1 and 3 of the non-PRRSV-infected pigs. Two pigs from group 1 died within 36 hours after bacterial challenge. Two pigs from group 3 were euthanized after developing central nervous system signs at 7 and 13 days postchallenge, respectively. One pig from group 6 was euthanized on day 24 after becoming moribund and exhibiting central nervous system signs.
Previously described protocols were followed for Salmonella spp. identification. 1 Non-lactose-fermenting colonies on either BG or MAC were inoculated into TSI agar and lysine iron agar (LIA). Isolates that produced an alkaline slant, acid butt, and H 2 S in the TSI agar and a positive LIA reaction (purple slant + purple butt) with H 2 S production were further tested with Salmonella O poly A-I and Vi antiserum. An agglutination reaction with poly O antiserum was considered definitive for Salmonella spp.
Virus isolation. All PRRSV-inoculated animals became viremic by day 6. A small percentage of pigs from groups 4, 8, and 9 were still viremic at termination of the study. Peak viral titers were observed on day 13 for all groups except 6 and 8 (Fig. 3) . Titers of these two groups were not significantly different from those of the other PRRSV-infected groups. Highest levels of viremia were noted in group 9 on day 13 but were not significantly different from levels in other PRRSV-inoculated groups that had been challenged with bacterial cultures.
Gross necropsy evaluation
Lungs were removed, lesions noted, and individual lobes separated and weighed. Heart and individual kidney weights were also recorded. Individual lung lobes were then evaluated Serology. Serum neutralization assay detected earliest neutralizing antibody beginning at day 13 in PRRSV-infected pigs. Remaining pigs had seroconverted by study termination. Groups not inoculated with PRRSV remained seronegative throughout the study. Earliest positive indirect fluorescent antibody results were obtained at day 6 in groups 6 and 9; all other PRRSV-inoculated groups were positive by day 13.
Gross lesions
Significant gross lesions were limited to pigs from groups 1, 3, and 6 that died after bacterial inoculation and to pigs from group 5 that were necropsied. Two pigs from group 1 had diffuse, severe fibrinous polyserositis, and thick, matted fibrin adhered to the visceral pleura and epicardial surfaces. Multifocal atelectasis and septal edema of the underlying pulmonary parenchyma was also seen. Two pigs from group 3 were euthanized on days 14 and 20, respectively. Grossly, both had meningitis. One pig from group 6 was euthanized on day 24 after becoming moribund and ex- hibiting central nervous system signs. At necropsy, this pig had bilateral cranioventral bronchopneumonia, multifocal ulcerative enterocolitis, and fibrinous meningitis. One pig from control group 10 had several coalescing pulmonary abscesses in lung lobes and fibrinous pleural adhesions. Necrotizing enterocolitis was seen in 4 of 10 Salmonella cholerasuis-inoculated pigs. Three pigs from group 8 had cranioventral bronchopneumonia.
Evaluation of lung weights revealed no statistically significant differences between groups of PRRSV-infected pigs and non-PRRSV-infected pigs. Lungs of those pigs exhibiting gross lesions were significantly heavier than those of other pigs within the groups.
Microscopic changes
Microscopic lesions consisted of mild proliferative interstitial pneumonia and peribronchiolar infiltrates of lymphohistiocytic cells (Fig. 4) , mild nonsuppura- tive myocarditis (Fig. 5) , lymph node hyperplasia, and mild, focal nonsuppurative encephalitis in PRRSVinoculated pigs (Fig. 6 ). Lesions were present in PRRSV-infected pigs in significant numbers (Fig. 7) . Other lesions observed were typical of bacterial infection. Pigs that died or were euthanized prior to termination of the study had lesions typical for the respective bacterial organisms, including fibrinous pleuritis/peritonitis (H. parasuis, Streptococcus suis), fibrinosuppurative meningoencephalitis (H. parasuis, Streptococcus suis), suppurative interstitial/bronchointerstitial pneumonia (H. parasuis, Streptococcus suis, Salmonella cholerasuis), and necrotizing enterocolitis (Salmonella cholerasuis).
Bacteriology
Haemophilus parasuis was recovered from samples of lung and exudate from the 2 pigs from group 1 that were euthanized prior to termination of the study. Salmonella cholerasuis was isolated from enrichment medium from all pigs in group 5 and from 2 pigs in group 6. No bacterial pathogens were isolated from the lungs from any pigs at the completion of the study. that died after bacterial inoculation. Both pigs from Results: phase II Based upon initial findings in phase I, including clinical signs and rectal temperatures, the period of time between viral and bacterial inoculation was shortened. Shortening of the time between inoculations was expected to increase susceptibility to the bacterial agents due to heightened immunosuppression as a result of depletion of PAMs during early phases of viremia. 13
Clinical findings
All PRRSV-infected pigs exhibited mild clinical signs similar to those previously described in phase I. Rectal temperatures in PRRSV-infected pigs were similar to those observed in phase I, rising significantly (P < 0.05) by 48 hours PI and maintained until study termination. Rectal temperatures in PRRSV-infected pigs of groups 2 and 6 remained higher than those of non-PRRSV-infected pigs. No significant differences were found between groups 3 and 4 after challenge with Streptococcus suis. Mortality was observed in groups 3 and 4 associated with central nervous system signs, including lateral recumbancy, paddling, and lateral nystagmus. Animals succumbed on days 3 and 5 after bacterial challenge in non-PRRSV-infected and PRRSV-infected groups, respectively.
Virus isolation. Pigs in PRRSV-infected groups became viremic as early as 3 days PI. Pigs in PRRSVinoculated groups had virus in thymus, bronchial lymph node, and lung. Levels in heart tissue were variable (Fig. 8) .
Bacteriology. Streptococcus suis was isolated from tissue samples submitted from inoculated pigs. No other bacterial pathogens were isolated.
Gross lesions
groups 3 and 4 had meningitis. Pigs in all other groups exhibited small, multiple foci of consolidation in cranioventral lung lobes on postmortem examination.
Evaluation of lung weights revealed no significant differences between PRRSV-infected and non-infected pigs.
Microscopic changes
Microscopic lesions consisted of mild bronchointerstitial pneumonia in a number of pigs, including controls from all groups. Mild, focal, nonsuppurative myocarditis was observed in a small number of PRRSV-inoculated pigs from all groups. The 2 pigs that died prior to termination of the study had brain and lung lesions typical of infection with Streptococcus suis.
Discussion
Responses of 4-6-week-old pigs were similar after challenge with PRRSV based upon clinical signs, microscopic changes, seroconversion, and virus isolation regardless of bacterial inoculums. Seroconversion appeared to be delayed in pigs inoculated with Salmonella cholerasuis. Prolonged and recurrent increases in rectal temperatures and clinical signs appear consistent with viremia or intermittent bacteremia. Lung, heart, and brain lesions were consistent with previous accounts of PRRSV infection in pigs of this age. 2, 3, 15 In contrast to previous research findings and field reports, infection with PRRSV did not potentiate bacterial infection. 3, 4, 9, 15 No significant differences in clinical parameters were observed after bacterial inoculation. This finding coincides with results from other investigators, who found no significant differences between pigs infected with PRRSV and Mycoplasma hyopneumoniae and their uninfected counterparts (Van Alstine WG, et al.: 1993, Abstr Conf Res Workers Anim Dis 47: 245) .
Observations under controlled experimental conditions did not support field reports. Stress and virulence factors may be involved under field conditions. Physical factors, including weaning, restraint, food and water restriction, environmental factors, including housing conditions, individual space, and ambient temperature variations, and infectious agents, whether viral or bacterial, are all stressors that may affect the immune system. 14 Inability of PRRSV to potentiate bacterial infections in a research setting may be the result of a decrease in the number of aggravating factors present in many management situations. PRRSV strain variation may also be a factor in differences in clinical disease, lesion severity, potentiation of bacterial disease, and immunosuppression. 4,13 Previous experiments have indicated that 1 strain of PRRSV causes alteration in the immune system, including early de-creases in PAMs and in the ability of these cells to synthesize superoxides. As infection progressed, PAMs exhibited enhanced superoxide synthesis. In this same experiment, antibody responses were enhanced after vaccination with pseudorabies and Brucella vaccines. 17 Similar effects may account for the absence of potentiation of bacterial pathogens in this experiment.
Findings from phases I and II of the study indicate that NEB-1 PRRSV does not potentiate bacterial pathogens while producing significant clinical signs and microscopic lesions. Mortality was significantly greater in groups receiving only bacterial inocula in phase I, and no difference in mortality was noted in phase II. Further research into strain differences and the resulting differences in clinical signs and pathological changes as well as the ability to interact with other potential pathogens should be considered.
